Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism BCL6 inhibitors(B-cell lymphoma 6 protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Molecular FormulaC21H19FN6 |
InChIKeyWSRZNMRSHUJOED-RBUKOAKNSA-N |
CAS Registry2728727-91-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diffuse Large B-Cell Lymphoma | Preclinical | GB | 01 Aug 2021 |